ReviewThe challenge of indication extrapolation for infliximab biosimilars
Under a Creative Commons license
open access
Keywords
Infliximab
Extrapolation
Biosimilars
Subsequent entry biologics
Immunogenicity
Monoclonal antibodies
Cited by (0)
Copyright © 2014 The Authors. Published by Elsevier Ltd.